IFLR1000

Search results

Narrow your search

Result types
Article type
Jurisdiction
Practice area
Industry sector
Bar admission

Showing 631 - 640 of 755 for "Healthcare" with applied filters

News & Analysis

Romania: NNDKP assists Medicover with the acquisition of Polaris Medical in Cluj-Napoca

31 January 2022 by Nestor Nestor Diculescu Kingston Petersen

NNDKP assisted Medicover, a leading provider of private medical services in Romania, in the transaction through which the company acquired Polaris Medical, in Cluj-Napoca, from the Socea family.
News & Analysis

Romania: Țuca Zbârcea & Asociații Appoints Six New Partners in Latest Round of Promotions

23 December 2021 by Ţuca Zbârcea & Asociaţii

Țuca Zbârcea & Asociații has announced six new Partner promotions, effective 1 January 2022.
News & Analysis

India: Carlyle Group’s investments in Viyash Life Sciences Private Limited, an integrated generic pharmaceuticals platform

24 November 2021 by L&L Partners

L&L Partners Law Offices advised the Carlyle Group (“Carlyle”), on setting up an integrated generic pharmaceuticals platform, known as Viyash Life Sciences Private Limited in partnership with ex-Mylan senior executive, Dr. Hari Babu Bodepudi and ex- founder of Laurus Labs, Dr. Srihari Raju Kalidindi. L&L has also advised Carlyle on all its follow-on investments into Viyash over a period of time.
News & Analysis

India: Carlyle Group’s generic pharma platform Viyash, invests in Appcure Labs and Appco Pharma LLC

24 November 2021 by L&L Partners

L&L Partners Law Offices advised the Carlyle Group on the acquisition of 100% stake of Appcure Labs Private Limited and the acquisition of majority stake in Appco Pharma LLC through its generic pharma platform, Viyash Life Sciences Private Limited.
News & Analysis

Luxembourg: Procaps Group, S.A. now listed on the Nasdaq Global Market

01 October 2021 by Arendt & Medernach

Arendt has assisted in a de-SPAC transaction in the international healthcare industry involving Luxembourg
News & Analysis

Egypt: Baker McKenzie announces global revenues of USD $3.1 Billion

30 September 2021 by Helmy Hamza & Partners

Baker McKenzie has announced revenues for the fiscal year ended 30 June 2021 (FY21) of USD $3.1 billion
News & Analysis

Benelux firm AKD appoints partners: Passing the baton to the next generation

10 June 2021 by AKD

AKD Benelux lawyers has appointed five new partners, four of them "home-grown”, managing partner Erwin Rademakers clarifies. “It gives immense pleasure to see colleagues developing and, as next-generation partners, contributing to building the future of our firm.”
News & Analysis

Helmy, Hamza & Partners, Baker McKenzie Cairo Strengthens its Corporate Practice in Egypt with the Hire of a New Partner, Hani Nassef

01 March 2021 by Helmy Hamza & Partners - Egypt

Former Eversheds Sutherland Partner, Hani Nassef, joins Helmy, Hamza & Partners, Baker McKenzie’s Cairo corporate team, brings significant public and private M&A and equity capital market expertise to the table
News & Analysis

Helmy, Hamza & Partners, Baker McKenzie Cairo advises National Service Projects Organization on its strategic collaboration with Grifols

02 December 2020 by Helmy Hamza & Partners

Cairo, Egypt, December 2, 2020 - Helmy, Hamza & Partners, Baker McKenzie Cairo office, has represented the National Service Projects Organization (NSPO), on a strategic joint venture with Grifols, one of the world's leading producers of plasma-derived medicines. The collaboration is a significant opportunity to develop the Egyptian plasma-derivatives market and promote its self-sufficiency.
News & Analysis

Homburger advised Vifor

16 November 2020 by Homburger

On November 9, 2020, Vifor Pharma and Angion Biomedica Corp. announced the signing of a licensing agreement for the commercialization of Angion’s ANG-3777
Load more